Concepedia

Styliani Karanika

SK

Statistics

Publications

13

Citations

887

H-Index

13

Active since

2014

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Johns Hopkins University

Boston Medical Center

Brown University

Johns Hopkins Medicine

Styliani Karanika is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and molecular oncology.

Publications per year

2014–2023

13

Publications

13

Androgen receptor inhibitor–induced “BRCAness” and PARP inhibition are synthetically lethal for castration-resistant prostate cancer

Likun Li, Styliani Karanika, Guang Yang et al. · Science Signaling · 2017 · 304 citations

Medicine, Oncology, Pharmacology +17

Targeting DNA Damage Response in Prostate Cancer by Inhibiting Androgen Receptor-CDC6-ATR-Chk1 Signaling

Styliani Karanika, Theodoros Karantanos, Likun Li et al. · Cell Reports · 2017 · 106 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Targeting Poly(ADP-Ribose) Polymerase and the c-Myb–Regulated DNA Damage Response Pathway in Castration-Resistant Prostate Cancer

Likun Li, Wenjun Chang, Guang Yang et al. · Science Signaling · 2014 · 87 citations

Life Sciences, Molecular Biology, Oncology +12

The absolute lymphocyte count can predict the overall survival of patients with non-small cell lung cancer on nivolumab: a clinical study

Theodoros Karantanos, Styliani Karanika, Bhavna Seth et al. · Clinical & Translational Oncology · 2018 · 72 citations

Medicine, Immunology, Oncology +14

Sex determines the presentation and outcomes in MPN and is related to sex-specific differences in the mutational burden

Theodoros Karantanos, Shruti Chaturvedi, Evan M. Braunstein et al. · Blood Advances · 2020 · 68 citations · Full text

Medicine, Genetics, Hematology +13

1–5 of 13